These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9498678)

  • 41. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
    Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
    Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioanalysis of HIV protease inhibitors in samples from sanctuary sites.
    Crommentuyn KM; Huitema AD; Beijnen JH
    J Pharm Biomed Anal; 2005 Jun; 38(1):139-47. PubMed ID: 15907632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching.
    Zhong L; Yeh KC
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):63-71. PubMed ID: 10574191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
    Hirabayashi Y; Tsuchiya K; Kimura S; Oka S
    Biomed Chromatogr; 2006 Jan; 20(1):28-36. PubMed ID: 15971289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection.
    Lamotte C; Peytavin G; Farinotti R
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):159-70. PubMed ID: 10670732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
    Weller DR; Brundage RC; Balfour HH; Vezina HE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Advances in the domain of HIV].
    Solignac M
    Presse Med; 2002 Jan; 31(2):87-90. PubMed ID: 11850992
    [No Abstract]   [Full Text] [Related]  

  • 49. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
    Rezk NL; Tidwell RR; Kashuba AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):241-7. PubMed ID: 15135096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma.
    Takahashi M; Yoshida M; Oki T; Okumura N; Suzuki T; Kaneda T
    Biol Pharm Bull; 2005 Jul; 28(7):1286-90. PubMed ID: 15997115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquid chromatographic assay for the non-peptidic protease inhibitor tipranavir in plasma.
    Sparidans RW; Dost F; Crommentuyn KM; Huitema AD; Schellens JH; Beijnen JH
    Biomed Chromatogr; 2006 Aug; 20(8):671-3. PubMed ID: 16799929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults.
    von Hentig N; Dauer B; Haberl A; Klauke S; Lutz T; Staszewski S; Harder S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):935-40. PubMed ID: 17665183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine.
    Gisolf EH; Enting RH; Jurriaans S; de Wolf F; van der Ende ME; Hoetelmans RM; Portegies P; Danner SA
    AIDS; 2000 Jul; 14(11):1583-9. PubMed ID: 10983645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients.
    Gervasoni C; Riva A; Rizzardini G; Clementi E; Galli M; Cattaneo D
    Antivir Ther; 2015; 20(4):449-51. PubMed ID: 25279606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection.
    Giraud E; Rey E; Tréluyer JM; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):86-90. PubMed ID: 16260190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection.
    Haas DW; Stone J; Clough LA; Johnson B; Spearman P; Harris VL; Nicotera J; Johnson RH; Raffanti S; Zhong L; Bergqwist P; Chamberlin S; Hoagland V; Ju WD
    Clin Pharmacol Ther; 2000 Oct; 68(4):367-74. PubMed ID: 11061576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA.
    Akeb F; Ferrua B; Creminon C; Roptin C; Grassi J; Nevers MC; Guedj R; Garraffo R; Duval D
    J Immunol Methods; 2002 May; 263(1-2):1-9. PubMed ID: 12009199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma.
    Wu EY; Wilkinson JM; Naret DG; Daniels VL; Williams LJ; Khalil DA; Shetty BV
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):373-80. PubMed ID: 9300874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients.
    Koks CH; Rosing H; Meenhorst PL; Bult A; Beijnen JH
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):345-51. PubMed ID: 7735482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.